New eye ointment aims to soothe dry, burning eyes

NCT ID NCT06596733

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether Vit-A-Vision, an eye ointment used up to three times daily, can improve dry eye symptoms like burning and irritation. About 77 adults with dry eye disease will use the ointment for 30 days. Researchers will measure tear film stability and symptom scores to see if the product provides relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Vit-A-Vision ointment (a lubricating eye ointment)

What this could lead to

If it works, this could provide a new over-the-counter option to relieve dry eye symptoms like burning and irritation.

What could go wrong

This is a small, early-stage trial with no comparison group, so results may not be conclusive. The ointment may not work for everyone, and side effects could include temporary blurred vision.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthenopia dry eye syndrome Eye Burns

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dept. of Ophthalmology Cologne Merheim

    RECRUITING

    Cologne, 51109, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••